Cargando…

Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes

PURPOSE: The aim of this study was to analyze the effect of timolol maleate (0.5%) eye drops in the treatment of myopic regression after laser-assisted in-situ keratomileusis (LASIK). METHODS: The study was conducted at a tertiary care eye hospital in north India between April 2017 & March 2018...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Aastha, Gour, Abha, Dave, Abhishek, Chouhan, Lokesh, Buckshey, Arjun, Mathur, Umang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856950/
https://www.ncbi.nlm.nih.gov/pubmed/33229683
http://dx.doi.org/10.4103/ijo.IJO_1503_20
_version_ 1783646347059003392
author Singh, Aastha
Gour, Abha
Dave, Abhishek
Chouhan, Lokesh
Buckshey, Arjun
Mathur, Umang
author_facet Singh, Aastha
Gour, Abha
Dave, Abhishek
Chouhan, Lokesh
Buckshey, Arjun
Mathur, Umang
author_sort Singh, Aastha
collection PubMed
description PURPOSE: The aim of this study was to analyze the effect of timolol maleate (0.5%) eye drops in the treatment of myopic regression after laser-assisted in-situ keratomileusis (LASIK). METHODS: The study was conducted at a tertiary care eye hospital in north India between April 2017 & March 2018 as a prospective interventional study. Patients who underwent uneventful myopic LASIK with hansatome mechanical keratome and presented with regression were included in the study. Baseline demographic characteristics, time to presentation with regression best-corrected visual acuity (BCVA), refraction, intraocular pressure, central corneal thickness and keratometry were recorded at baseline and at each follow-up visit. The enrolled patients were prescribed timolol maleate (0.5%) eyedrops twice daily. They were followed up every month till 3 months on timolol maleate (0.5%) eyedrops and at 6 months post stopping the treatment. RESULTS: Twenty-nine eyes of 15 patients were enrolled in the study. Mean pre LASIK spherical equivalent (SE) was – 7.48 ± 2.9 Diopters (Range-3.125 to –11.75 Diopters) and mean regression spherical equivalent was –1.02 ± 1.1 Diopters. There was a decrease in mean SE from presentation (intervention start point) up to 6 months follow-up (–1.34 ± 0.89 to –0.30 ± 0.29 Diopters). While posterior corneal curvature (K1 and K2 Back) changed significantly over treatment period (P = 0.0029, P = 0.0024 respectively), changes in anterior corneal curvature (K1 and K2 Front) were not significant (P = 0.05, P = 0.06 respectively). Central corneal thickness (CCT) and intraocular pressure (IOP) did not change significantly over treatment course. CONCLUSION: Timolol maleate (0.5%) eyedrop is an effective modality for the treatment of refractive regression post LASIK circumventing the need for laser re-treatment in such patients. The most probable mechanism is reversal of the anterior bowing of the cornea in response to intraocular pressure changes.
format Online
Article
Text
id pubmed-7856950
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-78569502021-02-05 Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes Singh, Aastha Gour, Abha Dave, Abhishek Chouhan, Lokesh Buckshey, Arjun Mathur, Umang Indian J Ophthalmol Original Article PURPOSE: The aim of this study was to analyze the effect of timolol maleate (0.5%) eye drops in the treatment of myopic regression after laser-assisted in-situ keratomileusis (LASIK). METHODS: The study was conducted at a tertiary care eye hospital in north India between April 2017 & March 2018 as a prospective interventional study. Patients who underwent uneventful myopic LASIK with hansatome mechanical keratome and presented with regression were included in the study. Baseline demographic characteristics, time to presentation with regression best-corrected visual acuity (BCVA), refraction, intraocular pressure, central corneal thickness and keratometry were recorded at baseline and at each follow-up visit. The enrolled patients were prescribed timolol maleate (0.5%) eyedrops twice daily. They were followed up every month till 3 months on timolol maleate (0.5%) eyedrops and at 6 months post stopping the treatment. RESULTS: Twenty-nine eyes of 15 patients were enrolled in the study. Mean pre LASIK spherical equivalent (SE) was – 7.48 ± 2.9 Diopters (Range-3.125 to –11.75 Diopters) and mean regression spherical equivalent was –1.02 ± 1.1 Diopters. There was a decrease in mean SE from presentation (intervention start point) up to 6 months follow-up (–1.34 ± 0.89 to –0.30 ± 0.29 Diopters). While posterior corneal curvature (K1 and K2 Back) changed significantly over treatment period (P = 0.0029, P = 0.0024 respectively), changes in anterior corneal curvature (K1 and K2 Front) were not significant (P = 0.05, P = 0.06 respectively). Central corneal thickness (CCT) and intraocular pressure (IOP) did not change significantly over treatment course. CONCLUSION: Timolol maleate (0.5%) eyedrop is an effective modality for the treatment of refractive regression post LASIK circumventing the need for laser re-treatment in such patients. The most probable mechanism is reversal of the anterior bowing of the cornea in response to intraocular pressure changes. Wolters Kluwer - Medknow 2020-12 2020-11-23 /pmc/articles/PMC7856950/ /pubmed/33229683 http://dx.doi.org/10.4103/ijo.IJO_1503_20 Text en Copyright: © 2020 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Singh, Aastha
Gour, Abha
Dave, Abhishek
Chouhan, Lokesh
Buckshey, Arjun
Mathur, Umang
Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
title Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
title_full Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
title_fullStr Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
title_full_unstemmed Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
title_short Effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: Clinical and topographical outcomes
title_sort effect of timolol maleate (0.5%) in the management of myopic regression post laser-assisted in-situ keratomileusis: clinical and topographical outcomes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856950/
https://www.ncbi.nlm.nih.gov/pubmed/33229683
http://dx.doi.org/10.4103/ijo.IJO_1503_20
work_keys_str_mv AT singhaastha effectoftimololmaleate05inthemanagementofmyopicregressionpostlaserassistedinsitukeratomileusisclinicalandtopographicaloutcomes
AT gourabha effectoftimololmaleate05inthemanagementofmyopicregressionpostlaserassistedinsitukeratomileusisclinicalandtopographicaloutcomes
AT daveabhishek effectoftimololmaleate05inthemanagementofmyopicregressionpostlaserassistedinsitukeratomileusisclinicalandtopographicaloutcomes
AT chouhanlokesh effectoftimololmaleate05inthemanagementofmyopicregressionpostlaserassistedinsitukeratomileusisclinicalandtopographicaloutcomes
AT bucksheyarjun effectoftimololmaleate05inthemanagementofmyopicregressionpostlaserassistedinsitukeratomileusisclinicalandtopographicaloutcomes
AT mathurumang effectoftimololmaleate05inthemanagementofmyopicregressionpostlaserassistedinsitukeratomileusisclinicalandtopographicaloutcomes